MedTrace Logo

VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)

NCT04757766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

The VAP-PRO-C6 is a Russian multicenter observational program to be implemented at the routine visits and assessments. The program will include patients with chronic venous disease of CEAP classes C6. This program is planned to be carried out in Russia in 2021-2022.

Conditions

  • Chronic Venous Insufficiency

Interventions

DRUG

in daily everyday routine practice

The treatment of patients with chronic venous disease of CEAP classes C6 will be consistent with routine clinical practice, local label for the medical use of drugs and the specific clinical situation.

Sponsors & Collaborators

  • Servier Russia

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04757766 on ClinicalTrials.gov